Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.

Saved in:
Bibliographic Details
Title: Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
Authors: Vandeputte C; GUTS research group, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Bregni G; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Gkolfakis P; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Guiot T; Nuclear medicine Imaging and Therapy Department, Institut Jules Bordet, Brussels, Belgium., Pretta A; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Kehagias P; GUTS research group, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Senti C; GUTS research group, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Reina EA; GUTS research group, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Van Bogaert C; GUTS research group, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Deleporte A; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium., Geboes K; Service of digestive oncology, Universitair Ziekenhuis Gent, Gent, Belgium., Delaunoit T; Oncology department, Hôpital de Jolimont, La Louvière, Belgium., Demolin G; Gastroenterology Department, Centre Hospitalier Chrétien St-Joseph, Liège, Belgium., Peeters M; Oncology department, Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium., D'Hondt L; Oncology department, Centre Hospitalier Universitaire, UCL Namur (site de Godinne), Belgium., Janssens J; Department of Gastroenterology, AZ Turnhout, Turnhout, Belgium., Carrasco J; Oncology department, Grand Hôpital de Charleroi, Charleroi, Belgium., Holbrechts S; Service of Medical Oncology, Centre Hospitalier Universitaire Ambroise Paré, Mons, Belgium., Goeminne JC; Service of Medical Oncology, Clinique et Maternité Ste Elizabeth, Namur, Belgium., Vergauwe P; Gastroenterology Department, AZ Groeninge, Kortrijk, Belgium., Van Laethem JL; Department of Gastroenterology and Digestive Oncology, Erasme Hospital, Brussels, Belgium., Flamen P; Nuclear medicine Imaging and Therapy Department, Institut Jules Bordet, Brussels, Belgium., Hendlisz A; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium; Université Libre de Bruxelles, Brussels, Belgium., Sclafani F; Gastrointestinal Unit, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium; Université Libre de Bruxelles, Brussels, Belgium. Electronic address: francesco.sclafani@bordet.be.
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2021 Dec; Vol. 20 (4), pp. 326-333. Date of Electronic Publication: 2021 Jul 24.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1938-0674
DOI:10.1016/j.clcc.2021.07.006